19 June 2013
Keywords: michael, fox, foundation, award, alnylam, usa-based, pharmaceuticals
Article | 22 August 2005
USA-based Alnylam Pharmaceuticals, an RNA interference therapeutics company, says that it has been awarded a grant from the Michael J ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 August 2005
15 August 2005
18 June 2013
© 2013 thepharmaletter.com